Michael Burwinkel

Michael Burwinkel

Auto-generated profile, based on publicly available information

Michael Burwinkel

Institut für Virologie, Freie Universität Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
CRConstanze Riemer
Constanze Riemer
SNSabine Neidhold
Sabine Neidhold
MBMichael Burwinkel
Michael Burwinkel
ASAnja Schwarz
Anja Schwarz
JSJulia Schultz
Julia Schultz
MBMichael Baier
Michael Baier

1 August 2004 in The American Journal of Pathology
Verified
Journal Article
Closed access
JSJulia Schultz
Julia Schultz
ASAnja Schwarz
Anja Schwarz
SNSabine Neidhold
Sabine Neidhold
MBMichael Burwinkel
Michael Burwinkel
CRConstanze Riemer
Constanze Riemer
MBMichael Baier
Michael Baier

1 October 2003 in Neuroscience Letters
Verified
Journal Article
Closed access
ASAnja Schwarz
Anja Schwarz
OKOliver Krätke
Oliver Krätke
MBMichael Burwinkel
Michael Burwinkel
CRConstanze Riemer
Constanze Riemer
JSJulia Schultz
Julia Schultz
MBMichael Baier
Michael Baier

28 November 2012 in Archives of Virology
Verified
Journal Article
Closed access
PDF file
WCWeidong Chai
Weidong Chai
MBMichael Burwinkel
Michael Burwinkel
ZWZhenya Wang
Zhenya Wang
CPChristiane Palissa
Christiane Palissa
BEBettina Esch
Bettina Esch
MSMichael F. G. Schmidt
Michael F. G. Schmidt

7 January 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZWZhenya Wang
Zhenya Wang
WCWeidong Chai
Weidong Chai
MBMichael Burwinkel
Michael Burwinkel
STSven Twardziok
Sven Twardziok
PWPaul Wrede
Paul Wrede
MSMichael F. G. Schmidt
Michael F. G. Schmidt
The control of infectious diseases such as swine influenza viruses (SwIV) plays an important role in food production both from the animal health and from the public health point of view. Probiotic microorganisms and other health improving food supplements have been given increasing attention in recent years, but, no information on the effects of probiotics on swine influenza virus is available. Here we address this question by assessing the inhibitory potential of the probiotic Enterococcus faecium NCIMB 10415 (E. faecium) on the replication of two porcine strains of influenza virus (H1N1 and H3N2 strain) in a continuous porcine macrophage cell line (3D4/21) and in MDBK cells. Cell cultures were treated with E. faecium at the non-toxic concentration of 1×106 CFU/ml in growth medium for 60 to 90 min before, during and after SwIV infection. After further incubation of cultures in probiotic-free growth medium, cell viability and virus propagation were determined at 48 h or 96 h post infection. The results obtained reveal an almost complete recovery of viability of SwIV infected cells and an inhibition of virus multiplication by up to four log units in the E. faecium treated cells. In both 3D4/21- and MDBK-cells a 60 min treatment with E. faecium stimulated nitric oxide (NO) release which is in line with published evidence for an antiviral function of NO. Furthermore, E. faecium caused a modified cellular expression of selected mediators of defence in 3D4-cells: while the expression of TNF-α, TLR-3 and IL-6 were decreased in the SwIV-infected and probiotic treated cells, IL-10 was found to be increased. Since we obtained experimental evidence for the direct adsorptive trapping of SwIV through E. faecium, this probiotic microorganism inhibits influenza viruses by at least two mechanisms, direct physical interaction and strengthening of innate defence at the cellular level.

1 September 2004 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
MBMichael Burwinkel
Michael Burwinkel
CRConstanze Riemer
Constanze Riemer
ASAnja Schwarz
Anja Schwarz
JSJulia Schultz
Julia Schultz
SNSabine Neidhold
Sabine Neidhold
MBMichael Baier
Michael Baier